BioAtla | Investor Presentation Deck | 44 slides · page 34 of 44
The table lists specific indications (NSCLC, Melanoma, Head and Neck, Ovarian) and their corresponding dosing schedules (Q2W, 3Q4W) and patient counts (N ~ 20 or 40).
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 4/4
disclaimer 1/1 table 1/1 title 2/2
Components 4
disclaimer data headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.